Skip to content

Effect of Sleep Restriction on Decision Making and Inflammation

Effect of Sleep Restriction on Decision Making and Inflammation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01989741
Enrollment
12
Registered
2013-11-21
Start date
2012-09-30
Completion date
2012-12-31
Last updated
2013-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Deprivation

Keywords

sleep restriction, decision making, wakefullness

Brief summary

* hypothesis: sleep restriction in healthy subject trigger alteration of decision making associated with immuno-inflammatory changes * inclusion criterias: healthy subjects, men, under 35 years, BMI\<26, no sleep troubles, intermediate chronotype * design: 12 subjects, longitudinal study 2 days of baseline, 7 night of sleep restriction (4h sleep/night), recovery (1, 2, 3 and 9 normal sleep nights). * parameters: decision making tests, reaction time, wakefulness test, biological parameters (cathecholamines, pro-inflammatory cytokines...), heart rate, blood pressure * control of sleep restriction: continuous polysomnographic survey

Interventions

OTHERSleep restriction

4 hours sleep by night during one week

Sponsors

Institut de Recherche Biomedicale des Armees
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy men, \< 35 yr old, BMI\<26, intermediate chronotype

Exclusion criteria

* sleep trouble, acute or chronique disease (cardiological, neurological...), women

Design outcomes

Primary

MeasureTime frameDescription
London tower test score (décision making)up to 3 days% of good score and mean response time resulting from London Tower test, assessed during baseline, sleep restriction (day 1 to day 5) and recovery (day 1 to day 3) at 10 AM

Secondary

MeasureTime frame
wakefulnessmaintenance of wakefulness test (MWT) score observed every day during baselline, sleep restriction and recovery at 09 AM, 12 AM, 4 PM and 7 PM
cognitive functionup to 3 days
Inflammationbiological marker of inflammation levels assessed every day during baseline, sleep restriction and recovery at 08 AM

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026